{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:37:27Z","timestamp":1786649847354,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>Uveal melanoma is a cancer (melanoma) of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). The liver is a frequent site for metastasis in patients with uveal melanoma. The interval between the diagnosis of the uveal melanoma and the diagnosis of the metastatic lesion can vary. Despite therapy, the median survival of those with liver metastasis is 5-7 months. We report here a rare case of choriodal melanoma in a 45-year-old male smoker presented with liver metastasis within just 8 months after completion of initial treatments consists of enucleation of eye and 3 Dimensional conformal radiation therapy (3D-CRT). The metastasis is an incidental finding on imaging after having some vague symptoms. This type of very early metastasis after completing initial treatment is very rare and proves the aggressiveness of the disease.<\/jats:p>","DOI":"10.4103\/0973-1482.157349","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:48:49Z","timestamp":1455842929000},"page":"957-960","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Choroidal melanoma of left eye with very early liver metastasis"],"prefix":"10.4103","volume":"11","author":[{"given":"Sanchayan","family":"Mandal","sequence":"first","affiliation":[{"name":"Departments of Radiotherapy, Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamohan","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Departments of Radiotherapy, Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Devleena","sequence":"additional","affiliation":[{"name":"Departments of Radiotherapy, Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra","family":"Sil","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","article-title":"Uveal melanoma: Epidemiological aspects","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archopht.1996.01100130103030","article-title":"Metastatic ocular and cutaneous melanoma: A comparison of patient characteristics and prognosis","volume":"114","author":"Albert","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Collaborative Ocular Melanoma Study Group. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: COMS report no. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.cmr.0000129377.22141.ea","article-title":"Phase I\/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver","volume":"14","author":"Agarwala","year":"2004","journal-title":"Melanoma Res"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","article-title":"Uveal melanoma","volume":"38","author":"Spagnolo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ijscr.2013.06.017","article-title":"A case of solitary pulmonary metastasis of choroidal melanoma with an exceptionally long disease-free period","volume":"4","author":"Komatsu","year":"2013","journal-title":"Int J Surg Case Rep"},{"key":"R8-20260109","first-page":"43","article-title":"Long-term risk of local failure after proton therapy for choroidal\/ciliary body melanoma","volume":"100","author":"Gragoudas","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0161-6420(87)33456-6","article-title":"Long-term results of proton beam irradiated uveal melanomas","volume":"94","author":"Gragoudas","year":"1987","journal-title":"Ophthalmology"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(88)33091-5","article-title":"Metastasis from uveal melanoma after proton beam irradiation","volume":"95","author":"Gragoudas","year":"1988","journal-title":"Ophthalmology"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/1097-0142(19901001)66:7<1596::AID-CNCR2820660726>3.0.CO;2-6","article-title":"Clinical prognostic factors in patients with posterior uveal malignant melanoma","volume":"66","author":"Augsburger","year":"1990","journal-title":"Cancer"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","article-title":"Screening for metastasis from choroidal melanoma: The collaborative ocular melanoma study group report 23","volume":"22","author":"Diener-West","year":"2004","journal-title":"J Clin Oncol"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Group COMS Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the collaborative ocular melanoma study (COMS): COMS report no. 15","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R14-20260109","first-page":"989","article-title":"Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation","volume":"2","author":"Koutsandrea","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1757-1626-2-189","article-title":"Metastatic melanoma presenting 24 years after surgical resection: A case report and review of the literature","volume":"2","author":"Slattery","year":"2009","journal-title":"Cases J"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.revmed.2003.11.002","article-title":"Ultra-late metastasis of ocular melanoma: About two cases","volume":"25","author":"Grosjean","year":"2004","journal-title":"Rev Med Interne"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/2047-783X-16-2-71","article-title":"Combined treatment of uveal melanoma liver metastases","volume":"16","author":"Brasiuniene","year":"2011","journal-title":"Eur J Med Res"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/ASO.2004.07.004","article-title":"Regional treatment options for patients with ocular melanoma metastatic to liver","volume":"11","author":"Feldman","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J","article-title":"Prognosis and treatment of disseminated uveal melanoma","volume":"72","author":"Kath","year":"1993","journal-title":"Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201511040-00056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:07Z","timestamp":1786647547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201511040-00056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.157349","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}